Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Menopause01:28

Menopause

158
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
158
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

369
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
369
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

496
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
496
Bone Disorders01:29

Bone Disorders

3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Hormonal Regulation01:40

Hormonal Regulation

43.5K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.5K
Infertility in Females01:28

Infertility in Females

292
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
292

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Health Care Encounters by Aboriginal and Torres Strait Islander People Aged 15-24 Years at Urban Aboriginal and Torres Strait Islander Community-Controlled Health Organisations in Southeast Queensland.

Journal of primary care & community health·2026
Same author

Correlates of hysterectomy in low- and middle-income countries: a systematic review.

Journal of global health·2026
Same author

Associations between childhood adversity and human papillomavirus vaccination in Australian women: a cross-sectional study.

Vaccine·2026
Same author

Parity, body mass index, smoking and risk of rheumatoid arthritis: data from the Australian Longitudinal Study on Women's Health.

BMC rheumatology·2026
Same author

Quality of life among women of reproductive age during the accumulation of multiple chronic conditions.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Maternal multimorbidity, lifestyle behaviours during pregnancy, and early-childhood growth trajectories: a register-based cohort study.

The Lancet regional health. Western Pacific·2026

Video Experimental Relacionado

Updated: Jul 1, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Optimizar la salud después de la menopausia temprana

Gita D Mishra1, Melanie C Davies2, Sarah Hillman3

  • 1Australian Women and Girls' Health Research Centre, School of Public Health, University of Queensland, Brisbane, QLD, Australia.

Lancet (London, England)
|March 8, 2024
PubMed
Resumen

La menopausia temprana, que ocurre antes de los 40-44 años, aumenta el riesgo de enfermedades crónicas y requiere una mejor orientación clínica. Ver la menopausia precoz como un espectro puede mejorar el diagnóstico y el tratamiento para las mujeres

Más Videos Relacionados

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
06:49

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

10.9K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.4K

Videos de Experimentos Relacionados

Last Updated: Jul 1, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
06:49

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

10.9K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.4K

Área de la Ciencia:

  • Endocrinología Reproductiva
  • Salud de las mujeres
  • Medicina Clínica

Sus antecedentes:

  • La menopausia generalmente ocurre alrededor de los 50-51 años.
  • La menopausia temprana (edades 40-44) afecta al 8-12% de las mujeres en todo el mundo.
  • La insuficiencia ovárica prematura (antes de los 40 años) afecta a un 2-4% adicional de las mujeres.

Objetivo del estudio:

  • Resaltar los riesgos para la salud asociados con la menopausia precoz y la insuficiencia ovárica prematura.
  • Abordar la brecha en la orientación clínica para la menopausia temprana.
  • Proponer un enfoque basado en el espectro para el manejo de la menopausia temprana.

Principales métodos:

  • Revisión de la evidencia sobre las consecuencias a corto y largo plazo de la menopausia precoz.
  • Desarrollo de un marco práctico para el diagnóstico y la gestión clínica.
  • Consideración de los síntomas, la edad del paciente, los antecedentes médicos y las prioridades individuales.

Principales resultados:

  • La menopausia precoz y la insuficiencia ovárica prematura están relacionadas con un mayor riesgo de osteoporosis y enfermedades cardiovasculares.
  • Las mujeres que experimentan la menopausia temprana pueden enfrentar angustia psicológica y sentirse sin apoyo.
  • Las directrices existentes tratan principalmente la insuficiencia ovárica prematura, dejando una brecha para la menopausia temprana.

Conclusiones:

  • La menopausia temprana debe considerarse en un continuo en lugar de por umbrales de edad estrictos.
  • Se propone un marco de gestión personalizado para optimizar la calidad de vida y los resultados de salud.
  • Se recomienda una mayor investigación para abordar las lagunas actuales de evidencia en la menopausia temprana.